Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 4Sanofi-Aventis Canada Inc.
02 1Blank
Reset all filters
01 11194875
02 21336777
03 22334870
Reset all filters
01 4Clopidogrel Bisulfate
02 1Blank
Reset all filters
01 4Tablet
02 1Blank
Reset all filters
01 12003-07-08
02 22012-08-22
03 22019-06-10
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Brand Name : PLAVIX
Patent Number : 2334870
Filing Date : 1999-06-10
Strength per Unit : 75 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Brand Name : PLAVIX
Patent Number : 1336777
Filing Date : 1988-02-08
Strength per Unit : 75 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Brand Name : PLAVIX
Patent Number : 1336777
Filing Date : 1988-02-08
Strength per Unit : 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-08-22
Date Granted : 1995-08-22
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Brand Name : PLAVIX
Patent Number : 2334870
Filing Date : 1999-06-10
Strength per Unit : 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-06-10
Date Granted : 2005-03-15
Patent Expiration Date : 2003-07-08
Date Granted :
Brand Name :
Patent Number : 1194875
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2003-07-08
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF